LPL Financial’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Buy |
43,052
+4,225
| +11% | +$19.7K | ﹤0.01% | 4941 |
|
|
2025
Q1 | $213K | Buy |
38,827
+1,800
| +5% | +$9.88K | ﹤0.01% | 4700 |
|
|
2024
Q4 | $126K | Sell |
37,027
-19,200
| -34% | -$65.1K | ﹤0.01% | 4826 |
|
|
2024
Q3 | $160K | Sell |
56,227
-18,450
| -25% | -$52.6K | ﹤0.01% | 4685 |
|
|
2024
Q2 | $168K | Buy |
74,677
+35,700
| +92% | +$80.3K | ﹤0.01% | 4522 |
|
|
2024
Q1 | $86.1K | Buy |
38,977
+5,602
| +17% | +$12.4K | ﹤0.01% | 4625 |
|
|
2023
Q4 | $78.4K | Buy |
+33,375
| New | +$78.4K | ﹤0.01% | 4522 |
|